Martin W. Rowbottom;Michael J. Hadd;Mark W. Holladay
发明人:
Michael J. Hadd,Mark W. Holladay,Martin W. Rowbottom
申请号：
US13819688
公开号：
US20130225578A1
申请日:
2011.08.31
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided herein are 7-cyclylquinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
